Lazard Asset Management
TERN

Lazard Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Lazard Asset Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,173
Closed -$378K – 2124
2026
Q1 		$378K Buy
+7,173
New +$295K ﹤0.01% 1450

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lazard Asset Management's TERN Position: Q2 2026 in Review

Lazard Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 7,173 shares — an estimated $378K sold.

Lazard Asset Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $378K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Lazard Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Lazard Asset Management sold 7,173 Terns Pharmaceuticals shares in Q2 2026, an estimated $378K.
  • Lazard Asset Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Lazard Asset Management's Terns Pharmaceuticals position peaked at $378K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.